EyePoint, Inc.
Company Information
Industry
Laboratory Analytical Instruments
SIC Code
3826
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
480 PLEASANT STREET, WATERTOWN, MA, 02472
Mailing Address
480 PLEASANT STREET, WATERTOWN, MA, 02472
Phone
617-926-5000
Fiscal Year End
1231
EIN
262774444
Financial Overview
FY2025
$418.46M
Total Assets
$81.96M
Total Liabilities
$336.50M
Stockholders' Equity
$101.82M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 24, 2026 | View on SEC |
| 8-K Current report of material events | March 20, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 5, 2026 | View on SEC |
| 10-K Annual financial report | March 5, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 24, 2026 | View on SEC |
Annual Reports
10-K
March 5, 2026
- DURAVYU™ is a potential first-in-class sustained-release treatment for wet AMD, offering significant patient convenience.
- Significant progress made in DURAVYU™ Phase 3 clinical trials for wet AMD and DME, with pivotal topline data for wet AMD anticipated in 2026.
Insider Trading
STRONG SELL
4 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 3826)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.